Media Advisory: Invitation for All BIO 2007 Registered Journalists, Interested in Business and Research in Europe.Press point Life sciences and biotechnology for Europe Monday, 07 May 2007, 10:00-11:00, EU Pavilion (stand #773) Boston Convention & Exhibition Center, Boston, MA (USA) WASHINGTON -- BIO 2007 Boston marks the third joint presentation of the European Commission European Commission, branch of the governing body of the European Union (EU) invested with executive and some legislative powers. Located in Brussels, Belgium, it was founded in 1967 when the three treaty organizations comprising what was then the European Community (the executive arm of the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community ), the European Patent Office (EPO EPO see erythropoietin. EPO Erythropoietin, see there ) and the European Medicines Agency The European Medicines Agency (EMEA) is a European agency for the evaluation of medicinal products. Until 2004, the European Medicines Agency was known as The European Agency for the Evaluation of Medicinal Products. Roughly parallel to the U.S. (EMEA (Europe, Middle East, Africa) Refers to that region of the world. For example, one might see products packaged differently for the UK, EMEA and Asia Pacific markets. ). The joint EU Pavilion and several international sessions at the world's largest biotechnology fair will highlight Europe's role in supporting research and innovation in the life sciences and promote Europe as a highly competitive, knowledge-based economy with opportunities for research, partnering and business development. Interested journalists will be able to discuss Europe's role and recent developments in the life sciences and biotechnology with the following directors from the European Commission and the European Patent Office: * Georgette Georgette Mary Richards’ coworker and Ted Baxter’s wife; epitomizes gullibility. [TV: “The Mary Tyler Moore Show” in Terrace, II, 70] See : Gullibility Georgette Ted Baxter’s pretty, ignorant wife. Lalis, Director of consumer goods consumer goods Any tangible commodity purchased by households to satisfy their wants and needs. Consumer goods may be durable or nondurable. Durable goods (e.g., autos, furniture, and appliances) have a significant life span, often defined as three years or more, and policy at the European Commission (Enterprise DG) * Christian Patermann, Director of biotechnology, agriculture, fisheries and food research at the European Commission (Research DG) * Octavi Quintana Trias, Director of health research at the European Commission (Research DG) * Andrzej Jan Rys, Director of public health and risk assessment at the European Commission (Health and Consumer Protection DG) * Sjoerd Hoekstra, Director of biotechnology examination and opposition at the European Patent Office More experts from the European Commission, the European Patent Office and the European Medicines Agency, speaking at the BIO convention, are available for one-on-one interviews. Please indicate your interest towards Michael.Wappelhorst@ec.europa.eu (cell phone +1-202-4132571 while at BIO). For more information on Europe's presence at BIO 2007 please see the media fact sheet at www.ec.europa.eu/research/eu-bio2007, the session agenda on page 3 of this note or visit the EU Pavilion (#773) at the BIO convention. What's new? * EU strategy for life sciences and biotechnology In a recent mid-term review of the EU Strategy on Life Sciences and Biotechnology for 2002-2010, the European Commission in April 2007 proposed a refocus of actions to promote a competitive and sustainable European knowledge based Bio-Economy More info: www.ec.europa.eu/biotechnology. * EU support for research in the life sciences Through the new Seventh Research Framework Programme (FP7, 2007-2013) the European Union annually provides about EU1 billion in European public funds See Fund, 3. See also: Public for life sciences research. These funds are allocated mainly through competitive calls inviting proposals for collaborative R&D projects. More info: www.ec.europa.eu/research/fp7. * European Technology Initiative "Innovative Medicines Initiative" By mid-May the Commission will adopt a proposal for a new European joint technology initiative (JTI JTI Japan Tobacco International JTI Jaan Tonisson Institute JTI Justice Teaching Institute JTI Joint Technology Initiative JTI Joint Training Institute JTI Job Training Initiative (EPA) JTI Joint TCIM Interface ), the Innovative Medicines Initiative (IMI IMI International Masonry Institute (Washington, DC) IMI Israel Military Industries IMI Institute of the Motor Industry IMI International Market Insight IMI Imposto Municipal Sobre Imóveis (Portugal) ). It is foreseen that the IMI JTI could take the form of a Joint Undertaking between the European Commission and the European Federation of Pharmaceutical Industries and Associations The European Federation of Pharmaceutical Industries and Associations or EFPIA is the organization representing the research-based pharmaceutical industry operating in Europe. (EFPIA EFPIA European Federation of Pharmaceutical Industries and Associations ), involving a joint budget in the order of EU1-2 billions. More information: * More info on the European Commission: www.ec.europa.eu/index_en.htm * More info on the European Patent Office: www.epo.org. * More info on the European Medicines Agency (EMEA, London): www.emea.eu.int. * FP7 (2007-2013), calls for proposals: www.cordis.europa.eu/fp7 * EU Strategy "Life Sciences & Biotechnology": www.ec.europa.eu/biotechnology * EU Biotechnology - Food and Feed: www.ec.europa.eu/food/food/biotechnology/index_en.htm * EU Pharmaceuticals: http://pharmacos.eudra.org The BIO International Convention 2007 is organised by BIO. The BIO organisation represents more than 1100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO is widely known for the BIO International Convention, a four-day annual biotechnology showcase that draws about 20,000 attendees. More info: www.bio2007.org. [TABLE OMITTED] For updates and more info please see: www.ec.europa.eu/research/eu-bio2007. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion